Charged particles in radiation oncology
暂无分享,去创建一个
[1] M. Krause,et al. Exploring the role of cancer stem cells in radioresistance , 2008, Nature Reviews Cancer.
[2] Yolande Lievens,et al. Cost-effectiveness of particle therapy: current evidence and future needs. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[3] K. Flippo,et al. Laser acceleration of quasi-monoenergetic MeV ion beams , 2006, Nature.
[4] T. Teshima,et al. Particle irradiation suppresses metastatic potential of cancer cells. , 2005, Cancer research.
[5] G Kraft,et al. Research needed for improving heavy-ion therapy , 2009 .
[6] Marco Durante,et al. Speed and accuracy of a beam tracking system for treatment of moving targets with scanned ion beams , 2009, Physics in medicine and biology.
[7] I. Kaplan,et al. Radiation Therapy , 2006 .
[8] C. Lawton. Should positive phase III clinical trial data be required before proton beam therapy is more widely adopted? No , 2009 .
[9] Keynote address—Adjuvant chemotherapy and cancer cure , 1982 .
[10] Nobuyuki Kanematsu,et al. Specification of Carbon Ion Dose at the National Institute of Radiological Sciences (NIRS). , 2007, Journal of radiation research.
[11] Anders Brahme,et al. Recent advances in light ion radiation therapy. , 2004, International journal of radiation oncology, biology, physics.
[12] N. Keating,et al. Comparative Analysis of Second Malignancy Risk in Patients Treated with Proton Therapy versus Conventional Photon Therapy , 2008 .
[13] H. Tsujii,et al. Curative treatment of Stage I non-small-cell lung cancer with carbon ion beams using a hypofractionated regimen. , 2007, International journal of radiation oncology, biology, physics.
[14] Torunn I Yock,et al. Technology Insight: proton beam radiotherapy for treatment in pediatric brain tumors , 2004, Nature Clinical Practice Oncology.
[15] J. Folkman. Angiogenesis in cancer, vascular, rheumatoid and other disease , 1995, Nature Medicine.
[16] E. Halperin. Particle therapy and treatment of cancer. , 2006, The Lancet. Oncology.
[17] G. Taucher‐Scholz,et al. The impact of conventional and heavy ion irradiation on tumor cell migration in vitro , 2007, International journal of radiation biology.
[18] P. Lambin,et al. Particle therapy in lung cancer: where do we stand? , 2008, Cancer treatment reviews.
[19] E. Hall. The Impact of Protons on the Incidence of Second Malignancies in Radiotherapy , 2007, Technology in cancer research & treatment.
[20] H. Tsujii,et al. Clinical advantages of carbon-ion radiotherapy , 2008 .
[21] André Wambersie,et al. Comparison of the Methods of Specifying Carbon Ion Doses at NIRS and GSI. , 2007, Journal of radiation research.
[22] E Pedroni,et al. Experimental characterization and physical modelling of the dose distribution of scanned proton pencil beams , 2005, Physics in medicine and biology.
[23] J. Debus,et al. Carbon ion radiotherapy for pediatric patients and young adults treated for tumors of the skull base , 2009, Cancer.
[24] T. Teshima,et al. Heavy ion irradiation inhibits in vitro angiogenesis even at sublethal dose. , 2003, Cancer research.
[25] Hirohiko Tsujii,et al. Particle radiation therapy using proton and heavier ion beams. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[26] Christian P Karger,et al. The future of heavy ion radiotherapy. , 2008, Medical physics.
[27] N. Wiklund,et al. Technology Insight: surgical robots—expensive toys or the future of urologic surgery? , 2004, Nature Clinical Practice Urology.
[28] Riwa Kishimoto,et al. Clinical Results of Carbon Ion Radiotherapy at NIRS. , 2007, Journal of radiation research.
[29] William Speier,et al. Is proton beam therapy cost effective in the treatment of adenocarcinoma of the prostate? , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[30] C A Tobias,et al. Radiological Physics Characteristics of the Extracted Heavy Ion Beams of the Bevatron , 1971, Science.
[31] Oliver Jäkel,et al. On the cost-effectiveness of Carbon ion radiation therapy for skull base chordoma. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[32] E. Rofstad,et al. Increased Metastatic Dissemination in Human Melanoma Xenografts after Subcurative Radiation Treatment , 2004, Cancer Research.
[33] B. Jones,et al. The case for particle therapy. , 2006, The British journal of radiology.
[34] F A Cucinotta,et al. Karyotypes of Human Lymphocytes Exposed to High-Energy Iron Ions , 2002, Radiation research.
[35] M Bues,et al. Advantage of protons compared to conventional X-ray or IMRT in the treatment of a pediatric patient with medulloblastoma. , 2004, International journal of radiation oncology, biology, physics.
[36] Marco Durante,et al. Cancer risk from exposure to galactic cosmic rays: implications for space exploration by human beings. , 2006, The Lancet. Oncology.
[37] Katia Parodi,et al. Comparison between in-beam and offline positron emission tomography imaging of proton and carbon ion therapeutic irradiation at synchrotron- and cyclotron-based facilities. , 2008, International journal of radiation oncology, biology, physics.
[38] E. J. Ainsworth,et al. Molecular and cellular radiobiology of heavy ions. , 1982, International journal of radiation oncology, biology, physics.
[39] D. de Ruysscher,et al. Current Clinical Evidence for Proton Therapy , 2009, Cancer journal.
[40] H. Tsujii,et al. Carbon ion radiation therapy for primary renal cell carcinoma: initial clinical experience. , 2008, International journal of radiation oncology, biology, physics.
[41] Irving L. Weissman,et al. Association of reactive oxygen species levels and radioresistance in cancer stem cells , 2009, Nature.
[42] T S Lawrence,et al. Recent advances in radiation oncology. , 1995, The New England journal of medicine.
[43] M Scholz,et al. RBE for carbon track-segment irradiation in cell lines of differing repair capacity. , 1999, International journal of radiation biology.
[44] K. Mills,et al. Heavy ion carcinogenesis and human space exploration , 2008 .
[45] H. Kooy,et al. Proton beam therapy , 2005, British Journal of Cancer.
[46] Dirk De Ruysscher,et al. Proton therapy in clinical practice: current clinical evidence. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[47] Michael Scholz,et al. Accuracy of the local effect model for the prediction of biologic effects of carbon ion beams in vitro and in vivo. , 2008, International journal of radiation oncology, biology, physics.
[48] Michael Scholz,et al. Effectiveness of carbon ion radiotherapy in the treatment of skull-base chordomas. , 2007, International journal of radiation oncology, biology, physics.
[49] Jean-Luc Balligand,et al. Irradiation-induced angiogenesis through the up-regulation of the nitric oxide pathway: implications for tumor radiotherapy. , 2003, Cancer research.
[50] Harald Paganetti,et al. Relative biological effectiveness (RBE) values for proton beam therapy. , 2002, International journal of radiation oncology, biology, physics.
[51] N. Hamada. Recent insights into the biological action of heavy-ion radiation. , 2009, Journal of radiation research.
[52] E. Hall,et al. Intensity-modulated radiation therapy, protons, and the risk of second cancers. , 2006, International journal of radiation oncology, biology, physics.
[53] Jacques Bernier,et al. Molecular therapy in head and neck oncology , 2009, Nature Reviews Clinical Oncology.
[54] J. P. Morgan. A patient's perspective on randomized clinical trials for proton radiotherapy. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[55] Masahiko Watanabe,et al. Comparison of biological effectiveness of carbon-ion beams in Japan and Germany. , 2009, International journal of radiation oncology, biology, physics.
[56] Susumu Kandatsu,et al. Carbon Ion Radiotherapy for Stage I Non-small Cell Lung Cancer Using a Regimen of Four Fractions during 1 Week , 2007, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[57] Alexei Vazquez,et al. The genetics of the p53 pathway, apoptosis and cancer therapy , 2008, Nature Reviews Drug Discovery.
[58] H. Paganetti. The impact of protons on the incidence of second malignancies in radiotherapy by Eric J. Hall; Supp.31-34 2007. , 2007, Technology in cancer research & treatment.
[59] Sairos Safai,et al. Should positive phase III clinical trial data be required before proton beam therapy is more widely adopted? No. , 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[60] D. Brenner,et al. Secondary neutrons in clinical proton radiotherapy: a charged issue. , 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[61] P. P. Reddy,et al. Cytogenetic damage in lymphocytes of rubber industry workers. , 1986, Environmental research.
[62] Carlo Greco,et al. Current status of radiotherapy with proton and light ion beams , 2007, Cancer.
[63] D. Nash,et al. Initial clinical experience with BL-J433. , 1968, The Journal of clinical pharmacology and the journal of new drugs.
[64] Y. Akino,et al. Carbon-ion beam irradiation effectively suppresses migration and invasion of human non-small-cell lung cancer cells. , 2009, International journal of radiation oncology, biology, physics.
[65] M. Durante,et al. X-rays vs. carbon-ion tumor therapy: cytogenetic damage in lymphocytes. , 2000, International journal of radiation oncology, biology, physics.
[66] R. Doll,et al. Cancer risks attributable to low doses of ionizing radiation: Assessing what we really know , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[67] H. Tsujii,et al. Carbon ion radiotherapy for elderly patients 80 years and older with stage I non-small cell lung cancer. , 2009, Lung cancer.